Skip to main content
MDLN
NASDAQ Industrial Applications And Services

Medline Prices 60M-Share Secondary at $35.50; Company to Buy Back $200M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$39.16
Mkt Cap
$51.521B
52W Low
$31.37
52W High
$50.876
52W Position info
25% above low
Off High info
23% below high
Rel. Volume info
4.3× avg
Market data snapshot near publication time

MDLN sits 25% above its 52-week low of $31.37 on elevated volume (4.3× avg).

Summary

Medline priced a 60 million-share secondary at $35.50, about $2.1 billion for selling sponsors, and will itself repurchase $200 million of stock and units at the same price.


Key Events · Financing and Capital Events · MDLN

  • Secondary Priced at $35.50

    Selling stockholders affiliated with Blackstone, Carlyle, Hellman & Friedman, GIC and ADIA are offering 60 million Class A shares at $35.50, with a 30-day option for 9 million more.

  • Company Gets No Proceeds

    Medline is not selling shares and will receive none of the roughly $2.1 billion in net proceeds, which go to the selling stockholders.

  • Company Repurchases $200 Million

    Medline and Medline Holdings will buy back $200 million of Class A stock and Common Units at the same per-equity price, retiring equivalent Class B shares, under the existing repurchase program.

  • Closing Set for November 23

    The offering is expected to close November 23, 2026, subject to customary conditions; the repurchase closes concurrently and is conditioned on the offering.


Analysis · MDLN · Industrial Applications And Services

The sponsor group (Blackstone, Carlyle, Hellman & Friedman, GIC, ADIA) is selling 60 million Class A shares at $35.50, roughly $2.1 billion of stock, and Medline itself gets none of it. The offset is a $200 million repurchase by Medline and Medline Holdings at the same price, which retires shares and Class B stock and counts against the existing buyback. The offering price sits below today's $39.16 quote, so the deal is being absorbed at a discount to the current market. The overhang is large and the selling is sponsor liquidity, not a view on operations, but it lands while the company is still dealing with the bed field action and FDA scrutiny.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDLN was trading at $39.16 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $51.5B. The 52-week trading range was $31.37 to $50.88. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDLN - Latest Insights

MDLN
Nov 17, 2026, 10:23 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $37.51
Real-time Price: $38.18 info
Change: +$0.665 (+2%) info
Market Cap: $50.166B info
MDLN
Nov 16, 2026, 6:42 AM EST
Filing Type: S-1
Importance Score:
8
Price at Filing: $39.24
Real-time Price: $38.18 info
Change: -$1.06 (-3%) info
Market Cap: $50.166B info
MDLN
Nov 13, 2026, 4:58 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $39.82
Real-time Price: $38.18 info
Change: -$1.64 (-4%) info
Market Cap: $50.166B info
MDLN
Nov 04, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $40.35
Real-time Price: $38.18 info
Change: -$2.18 (-5%) info
Market Cap: $50.166B info
MDLN
Nov 04, 2026, 7:34 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.15
Real-time Price: $38.18 info
Change: +$1.02 (+3%) info
Market Cap: $50.166B info